The Democratic-controlled U.S. Senate Appropriations Committee urged HRSA to penalize drug manufacturers over 340B contract pharmacy restrictions.

Senate Appropriators Urge HRSA to Penalize Drug Makers That Impose 340B Contract Pharmacy Conditions

August 3, 2023 Tom Mirga, Editor at Large Views

Federal health care officials should use fines and “any available measures” to punish drug makers that deny 340B pricing for [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!